Multivariable analysis of association of beta-blocker use and survival in advanced ovarian cancer

被引：0
|
作者：
Gonzalez, R. [1 ]
Gockley, A. A. [2 ]
Melamed, A. [1 ]
Clark, R. M. [2 ]
Schorge, J. O. [1 ]
del Carmen, M. G. [3 ]
Berkowitz, R. S. [4 ]
Horowitz, N. S. [4 ]
Muto, M. G. [5 ]
Worley, M. J., Jr. [6 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Harvard Univ, Massachusetts Gen Hosp, Boston, MA USA
[4] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
GYNECOLOGIC ONCOLOGY | 2018年 / 149卷
关键词：
D O I：
10.1016/j.ygyno.2018.04.477
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
467
引用
收藏
页码：209 / 210
页数：2
相关论文
共 50 条
  • [21] Beta-blocker use and urothelial bladder cancer survival: a Swedish register-based cohort study
    Udumyan, Ruzan
    Botteri, Edoardo
    Jerlstrom, Tomas
    Montgomery, Scott
    Smedby, Karin E.
    Fall, Katja
    ACTA ONCOLOGICA, 2022, 61 (08) : 922 - 930
  • [22] NIFEDIPINE AND BETA-BLOCKER - POTENTIALLY DANGEROUS ASSOCIATION
    MOTTE, G
    CHANU, B
    SEBAG, C
    BENAIM, P
    NOUVELLE PRESSE MEDICALE, 1980, 9 (06): : 379 - 380
  • [23] The association of beta-blocker use with mortality in elderly patients with congestive heart failure and advanced chronic kidney disease
    Molnar, Amber O.
    Petrcich, William
    Weir, Matthew A.
    Garg, Amit X.
    Walsh, Michael
    Sood, Manish M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (05) : 782 - 789
  • [24] Association between beta-blocker atenolol use and prostate cancer upgrading in active surveillance1
    Zahalka, Ali H.
    Fram, Ethan
    Garden, Evan
    Howard, Lauren
    Wiggins, Emily
    Babar, Mustufa
    Annam, Jay
    Reagan, Allison
    Eilender, Benjamin
    de Hoedt, Amanda
    Freedland, Stephen J.
    Tewari, Ash
    Watts, Kara L.
    BJUI COMPASS, 2024, 5 (11): : 1095 - 1100
  • [25] Potential systemic effects of beta-blocker use in prostate cancer patients
    Grytli, Helene H.
    Ramberg, Haakon
    Braadland, Peder R.
    Nielsen, Heidi K.
    Guldvik, Ingrid J.
    Tasken, Kristin A.
    CANCER RESEARCH, 2018, 78 (16) : 85 - 86
  • [26] In Reply: Beta-Blocker Use in Refractory Ascites
    Liu, Mengfei
    Simonetto, Douglas A.
    MAYO CLINIC PROCEEDINGS, 2019, 94 (11) : 2364 - 2365
  • [27] DETECTION OF BETA-BLOCKER USE IN PEOPLE WITH ASTHMA
    GRAFT, DF
    FOWLES, J
    MCCOY, CE
    LAGER, RA
    ANNALS OF ALLERGY, 1992, 69 (05): : 449 - 453
  • [28] Association between perioperative beta blocker use and cancer survival following surgical resection
    Musselman, Reilly P.
    Bennett, Sean
    Li, Wenbin
    Mamdani, Muhammad
    Gomes, Tara
    van Walraven, Carl
    Boushey, Robin
    Al-Obeed, Omar
    Al-Omran, Mohammed
    Auer, Rebecca C.
    EJSO, 2018, 44 (08): : 1164 - 1169
  • [29] Beta-blocker use in decompensated heart failure
    Alharethi K.
    Hershberger R.E.
    Current Heart Failure Reports, 2006, 3 (2) : 75 - 80
  • [30] IS THE USE OF BETA-BLOCKER THERAPY DECREASED IN THE ELDERLY
    FORMAN, DE
    WEI, JY
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1991, 39 (08) : A49 - A49
12345